New stent study aims to restore leg blood flow

NCT ID NCT02793492

Ongoing Disease control Sponsor: Terumo Medical Corporation Source: ClinicalTrials.gov ↗

First seen Mar 30, 2026 · Last updated May 24, 2026 · Updated 5 times

Summary

This study tests a new self-expanding stent (Misago® RX) to treat blocked or narrowed iliac arteries in the pelvis. About 75 people with moderate to severe leg pain or early tissue damage will receive the stent. The main goal is to see if the stent safely keeps the artery open for at least 9 months without major problems like limb loss or repeat procedures.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ILIAC ARTERY STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Cardiovascular Institute of the South

Lafayette, Louisiana, 70506, United States
ClinRe Inc. Advanced Heart and Vein Center

Thornton, Colorado, 80023, United States
First Coast Cardiovascular Institute

Jacksonville, Florida, 32256, United States
Holy Name Medical Center

Teaneck, New Jersey, 07666, United States
Novant Health

Matthews, North Carolina, 28105, United States
Texas Tech University Health Sciences Center

Lubbock, Texas, 79430, United States
The Christ Hospital

Cincinnati, Ohio, 45219, United States
The Heart Hospital Baylor Plano

Plano, Texas, 75093, United States
University of Florida Health

Gainesville, Florida, 32610, United States

Conditions

Explore the condition pages connected to this study.

ILIAC ARTERY STENOSIS